CHIRP brings scientists and clinicians from various disciplines throughout Washington University together to conduct clinical research using psychedelics as medical treatment.
The research team investigates the how, why and for whom psychedelic treatments may be effective, and how those treatments may work in real-world settings.
Our research team draws upon extensive experience conducting industry sponsored clinical trials and in the design and implementation of our own studies.
We are the first clinical research group in the state of Missouri and one of less than 30 academic centers in the United States conducting clinical research trials safely and legally with Schedule 1 substances like psilocybin.
For more information about how to determine if a clinical trial is an Applicable Clinical Trial that must be registered with ClinicalTrials.gov, click here
We would love to hear about your research idea or project.
Our team guides researchers in setting up their own clinical trial.
Contact CHIRP for assistance with:
Visit CHIRP’s Guide to Starting Clinical Research to find resources to assist in conducting your research from start up to close out.
Researchers, if you have received consultation services or funding from CHIRP, please cite us in your manuscripts!
‘This work was [supported/funded] by the Center for Holistic Interdisciplinary Research in Psychedelics (CHIRP), a Here and Next Transcend Initiative funded by Washington University in St. Louis.’